Compounds > 3-4-dihydroxyphenylpropionic-acid

3-4-dihydroxyphenylpropionic-acid and Alzheimer-Disease

3-4-dihydroxyphenylpropionic-acid has been researched along with Alzheimer-Disease* in 1 studies

Other Studies

1 other study(ies) available for 3-4-dihydroxyphenylpropionic-acid and Alzheimer-Disease

Article	Year
Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides. Bioorganic & medicinal chemistry letters, 2016, 11-15, Volume: 26, Issue:22 Amyloid-β (Aβ) deposition and oxidative stress observed in the brains of patients with Alzheimer's disease (AD) are important targets for therapeutic intervention. In this study, we conjugated the antioxidants caffeic acid (CA) and dihydrocaffeic acid (DHCA) to Aβ Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Antioxidants; Caffeic Acids; Cell Line, Tumor; Humans; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Protein Aggregates	2016

Article

Year

Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides.

Bioorganic & medicinal chemistry letters, 2016, 11-15, Volume: 26, Issue:22

Amyloid-β (Aβ) deposition and oxidative stress observed in the brains of patients with Alzheimer's disease (AD) are important targets for therapeutic intervention. In this study, we conjugated the antioxidants caffeic acid (CA) and dihydrocaffeic acid (DHCA) to Aβ

Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Antioxidants; Caffeic Acids; Cell Line, Tumor; Humans; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Protein Aggregates

2016